These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
339 related articles for article (PubMed ID: 30155693)
1. Synergistic antiproliferative effects of curcumin and celecoxib in hepatocellular carcinoma HepG2 cells. Abdallah FM; Helmy MW; Katary MA; Ghoneim AI Naunyn Schmiedebergs Arch Pharmacol; 2018 Dec; 391(12):1399-1410. PubMed ID: 30155693 [TBL] [Abstract][Full Text] [Related]
2. Combined cetuximab and celecoxib treatment exhibits a synergistic anticancer effect on human oral squamous cell carcinoma in vitro and in vivo. Qian M; Qian D; Jing H; Li Y; Ma C; Zhou Y Oncol Rep; 2014 Oct; 32(4):1681-8. PubMed ID: 25328959 [TBL] [Abstract][Full Text] [Related]
3. Cisplatin and curcumin co-loaded nano-liposomes for the treatment of hepatocellular carcinoma. Cheng Y; Zhao P; Wu S; Yang T; Chen Y; Zhang X; He C; Zheng C; Li K; Ma X; Xiang G Int J Pharm; 2018 Jul; 545(1-2):261-273. PubMed ID: 29730175 [TBL] [Abstract][Full Text] [Related]
4. Combining celecoxib with sorafenib synergistically inhibits hepatocellular carcinoma cells in vitro. Morisaki T; Umebayashi M; Kiyota A; Koya N; Tanaka H; Onishi H; Katano M Anticancer Res; 2013 Apr; 33(4):1387-95. PubMed ID: 23564777 [TBL] [Abstract][Full Text] [Related]
5. Curcumin inhibits proliferation of hepatocellular carcinoma cells through down regulation of DJ-1. Han L; Wang Y; Sun S Cancer Biomark; 2020; 29(1):1-8. PubMed ID: 32417759 [TBL] [Abstract][Full Text] [Related]
6. The role of the vascular endothelial growth factor/vascular endothelial growth factor receptors axis mediated angiogenesis in curcumin-loaded nanostructured lipid carriers induced human HepG2 cells apoptosis. Wang F; He Z; Dai W; Li Q; Liu X; Zhang Z; Zhai D; Chen J; Chen W J Cancer Res Ther; 2015; 11(3):597-605. PubMed ID: 26458588 [TBL] [Abstract][Full Text] [Related]
7. Catalpol synergistically potentiates the anti-tumour effects of regorafenib against hepatocellular carcinoma via dual inhibition of PI3K/Akt/mTOR/NF-κB and VEGF/VEGFR2 signaling pathways. El-Hanboshy SM; Helmy MW; Abd-Alhaseeb MM Mol Biol Rep; 2021 Nov; 48(11):7233-7242. PubMed ID: 34596810 [TBL] [Abstract][Full Text] [Related]
8. Curcumin-loaded galactosylated BSA nanoparticles as targeted drug delivery carriers inhibit hepatocellular carcinoma cell proliferation and migration. Huang Y; Hu L; Huang S; Xu W; Wan J; Wang D; Zheng G; Xia Z Int J Nanomedicine; 2018; 13():8309-8323. PubMed ID: 30584302 [TBL] [Abstract][Full Text] [Related]
9. Kanglaite enhances the efficacy of cisplatin in suppression of hepatocellular carcinoma via inhibiting CKLF1 mediated NF-κB pathway and regulating transporter mediated drug efflux. Chen C; Ai QD; Wei YH J Ethnopharmacol; 2021 Jan; 264():113388. PubMed ID: 32918990 [TBL] [Abstract][Full Text] [Related]
10. Piperine and Celecoxib synergistically inhibit colon cancer cell proliferation via modulating Wnt/β-catenin signaling pathway. Srivastava S; Dewangan J; Mishra S; Divakar A; Chaturvedi S; Wahajuddin M; Kumar S; Rath SK Phytomedicine; 2021 Apr; 84():153484. PubMed ID: 33667839 [TBL] [Abstract][Full Text] [Related]
11. Doxorubicin and curcumin co-delivery by lipid nanoparticles for enhanced treatment of diethylnitrosamine-induced hepatocellular carcinoma in mice. Zhao X; Chen Q; Li Y; Tang H; Liu W; Yang X Eur J Pharm Biopharm; 2015 Jun; 93():27-36. PubMed ID: 25770771 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of nuclear factor κB transcription activity drives a synergistic effect of cisplatin and oridonin on HepG2 human hepatocellular carcinoma cells. Dong X; Liu F; Li M Anticancer Drugs; 2016 Apr; 27(4):286-99. PubMed ID: 26704389 [TBL] [Abstract][Full Text] [Related]
13. Silk fibroin nanoparticles for celecoxib and curcumin delivery: ROS-scavenging and anti-inflammatory activities in an in vitro model of osteoarthritis. Crivelli B; Bari E; Perteghella S; Catenacci L; Sorrenti M; Mocchi M; Faragò S; Tripodo G; Prina-Mello A; Torre ML Eur J Pharm Biopharm; 2019 Apr; 137():37-45. PubMed ID: 30772432 [TBL] [Abstract][Full Text] [Related]
14. Mannose-mediated inhibitory effects of PA-MSHA on invasion and metastasis of hepatocellular carcinoma via EGFR/Akt/IκBβ/NF-κB pathway. Li T; Dong ZR; Guo ZY; Wang CH; Zhi XT; Zhou JW; Li DK; Chen ZT; Chen ZQ; Hu SY Liver Int; 2015 Apr; 35(4):1416-29. PubMed ID: 25066210 [TBL] [Abstract][Full Text] [Related]
15. Involvement of NF-kappaB activation in the apoptosis induced by extracellular adenosine in human hepatocellular carcinoma HepG2 cells. Wu LF; Li GP; Su JD; Pu ZJ; Feng JL; Ye YQ; Wei BL Biochem Cell Biol; 2010 Aug; 88(4):705-14. PubMed ID: 20651843 [TBL] [Abstract][Full Text] [Related]
16. Genistein potentiates the effect of arsenic trioxide against human hepatocellular carcinoma: role of Akt and nuclear factor-κB. Ma Y; Wang J; Liu L; Zhu H; Chen X; Pan S; Sun X; Jiang H Cancer Lett; 2011 Feb; 301(1):75-84. PubMed ID: 21078540 [TBL] [Abstract][Full Text] [Related]
17. Total alkaloids of Rubus aleaefolius Poir inhibit hepatocellular carcinoma growth in vivo and in vitro via activation of mitochondrial-dependent apoptosis. Zhao J; Chen X; Lin W; Wu G; Zhuang Q; Zhong X; Hong Z; Peng J Int J Oncol; 2013 Mar; 42(3):971-8. PubMed ID: 23338043 [TBL] [Abstract][Full Text] [Related]
18. Mitochondria-targeted antioxidant and glycolysis inhibition: synergistic therapy in hepatocellular carcinoma. Dilip A; Cheng G; Joseph J; Kunnimalaiyaan S; Kalyanaraman B; Kunnimalaiyaan M; Gamblin TC Anticancer Drugs; 2013 Oct; 24(9):881-8. PubMed ID: 23872912 [TBL] [Abstract][Full Text] [Related]
19. Macrolide antibiotics differentially influence human HepG2 cytotoxicity and modulate intrinsic/extrinsic apoptotic pathways in rat hepatocellular carcinoma model. Abdel-Hamid NI; El-Azab MF; Moustafa YM Naunyn Schmiedebergs Arch Pharmacol; 2017 Apr; 390(4):379-395. PubMed ID: 28070612 [TBL] [Abstract][Full Text] [Related]
20. Curcumin-loaded nanostructured lipid carrier induced apoptosis in human HepG2 cells through activation of the DR5/caspase-mediated extrinsic apoptosis pathway. Wang F; Ye X; Zhai D; Dai W; Wu Y; Chen J; Chen W Acta Pharm; 2020 Jun; 70(2):227-237. PubMed ID: 31955141 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]